Themis Medicare informs about analyst meet

17 Feb 2023 Evaluate

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’) read with part A of Schedule III of the Listing Regulations, Themis Medicare has informed that the management of the Company did a one-on-one physical meeting with Analysts/Investors ‘Nuvama Wealth Management’ on Thursday, 16th February 2023 at the company's Office. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company: www.themismedicare.com.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

75.54 0.28 (0.37%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×